About the PMI Evolve Project

About page photo

Malaria is a leading cause of illness and death across sub-Saharan Africa. Yet, thanks to the generosity of the American people and steady support from the U.S. Congress, the U.S. President's Malaria Initiative (PMI) has helped lead global efforts that have saved 11.7 million lives and prevented more than 2 billion malaria infections since 2000. In January 2023, the United States continued its investments in tackling this deadly disease, through the awarding of a new, five-year contract, the PMI Evolving Vector Control to Fight Malaria Project, known as PMI Evolve

PMI Evolve is supporting PMI, as well as U.S. Agency for International Development (USAID) missions and bureaus with the planning, implementing, and monitoring of malaria vector control programs that include interventions such as entomological monitoring, indoor residual spraying (IRS), distributing insecticide-treated nets (ITNs), and larval source management (LSM). PMI Evolve is strengthening the capacity of local institutions, including countries’ national malaria programs, district health offices, and research institutions to independently conduct vector control programs. The project is also responsible for program evaluation and conducting operations research on new vector control innovations. PMI Evolve is incorporating gender equity and social inclusion (GESI) and climate adaptation and mitigation initiatives as cross-cutting themes with the overall goal of ending malaria faster.  

The project is working in 21 PMI partner countries: Burkina Faso, Burundi, Cambodia, Cameroon, Cote d’Ivoire, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Liberia, Madagascar, Malawi, Mozambique, Niger, Nigeria, Rwanda, Senegal, Sierra Leone, Togo, Uganda, and Zambia.

PMI Evolve is led by Abt Associates in partnership with Population Services International, PATH, Tropical Health, and EnCompass LLC, along with the support of BAO Systems LLC, Cross Cut, Dimagi, Inc., Health Information Systems Program (HISP) Centre at the University of Oslo (UiO) and its affiliates in West and Central Africa and Uganda, Malaria Consortium, and the University of California, San Francisco (UCSF) Malaria Elimination Initiative.